Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial is evaluating SX-682 in combination with pembrolizumab for metastatic or recurrent stage IIIC or IV non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study. [Phase 2]
A Phase II randomized trial is evaluating cemiplimab plus OSE2101 (TEDOPI) as maintenance therapy in ctDNA-positive non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
This Bristol-Myers Squibb sponsored study focuses on patient and physician preferences for treatments in resectable non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Influence of a PSychological Intensive Support Program for Lung Cancer Patients ON Post-operative Outcomes. [NA]
This entry describes a clinical trial evaluating the effect of a Psychological Intensive Support Program on postoperative outcomes in non-sm…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis [NA]
This ClinicalTrials.gov update describes a study evaluating residual disease in resected non-small cell lung cancer using circulating tumor …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of GV20-0251 in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
GV20 Therapeutics is evaluating GV20-0251 in a Phase 1/2 trial for adults with various solid tumors, and the study is currently recruiting. …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers [Phase 2]
Phase 2 clinical trial focusing on methods to characterize resistance to antibody-drug conjugates in solid tumors and to identify clinically…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
This clinical trial investigates methylation markers for early-stage non-small cell lung cancer in patients treated with the Co-ablation Sys…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer [Phase 2]
Phase II clinical study to evaluate HLX43 in combination with Serplulimab for advanced lung cancer; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer [Phase 2]
Phase II study of Pyrotinib as first-line therapy for HER2-amplified/mutated advanced non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer [NA]
Clinical trial assessing the efficiency of offline adaptive radiotherapy for advanced non-small cell lung cancer is currently recruiting, sp…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
This clinical trial update discusses survival analysis and prognostic biomarker exploration for postoperative adjuvant therapy patterns in n…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer [Phase 2]
This document notes that SHR-A2102 is being evaluated in a Phase 2 trial in combination with other anti-tumor therapies for resectable non-s…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab [Phase 2]
This clinical trial update describes a Phase 2 randomized study comparing standard-of-care treatment to an immune-based combination for rela…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV [NA]
A clinical trial update examining whether food preferences influence undernutrition in treated patients with stage IV non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations
A prospective cohort study in locally advanced and metastatic non-small cell lung cancer patients with activating EGFR mutations is currentl…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Postoperative Pulmonary Function Assessment Based on Deep Learning Study [NA]
This clinical trial registry entry from The Chinese University of Hong Kong describes evaluating postoperative pulmonary function in non-sma…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. [NA]
A clinical trial investigating a process to optimize decisions about continuing or stopping cancer treatments in patients with advanced non-…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding durvalumab to radiation therapy can prevent progression of non-small cell lung cancer;…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer [Phase 2]
The document reports a Phase 2 clinical trial update for Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in advanced or unresectable/metastatic …
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC [Phase 2]
A Phase 2 clinical trial is investigating an osimertinib-based adaptive treatment guided by ctDNA EGFR mutation monitoring in locally advanc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update examining how infusion timing affects pathologic response to neoadjuvant immunotherapy in resectable non-small…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of YL202 in Selected Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study of YL202 in selected patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and head and nec…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a carcinoembryonic antigen (CEA)-targeted CAR-T therapy in patients with CEA-positive advanced solid tumors, inc…